Oventus Medical signed two contracts in the US for OSA's treatment

  • Nov 18, 2019 AEDT
  • Team Kalkine

Oventus Medical Limited (ASX: OVN) has signed two additional contracts in the US sleep market with clinics under which Oventus devices would be used for the treatment of patients diagnosed with Obstructive Sleep Apnoea (OSA).

Highlights

  • The first Californian lab in lab agreement is signed with Californian Center for Sleep Disorders.
  • In North Carolina, Feeling Great Sleep entered a lab in lab deal across three sites with minimum monthly quotas of 20 devices each month each site, with the launch planned for January 2020.
  • In the last 4 months, Contract negotiation pipeline for lab in lab model has doubled up.

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK